Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors
ConclusionsRisk scoring using baseline PLR, presence of liver metastasis, baseline albumin, and baseline ECOG PS may effectively predict OS and PFS in UC patients receiving ICI.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Julie M. Shabto,
Dylan J. Martini,
Yuan Liu,
Deepak Ravindranathan,
Jacqueline Brown,
Emilie E. Hitron,
Greta A. Russler,
Sarah Caulfield,
Haydn Kissick,
Mehrdad Alemozaffar,
Kenneth Ogan,
Wayne B. Harris,
Viraj A. Master,
Omer Kucuk,
Bradle Tags: ORIGINAL RESEARCH Source Type: research